银屑病与新发静脉血栓栓塞及外周血管病的关联:系统评价与Meta分析
该系统评价与Meta分析纳入13项队列研究共12 435 982名参与者,评估银屑病患者新发静脉血栓栓塞(VTE)和外周血管病(PVD)的风险。结果显示银屑病患者新发VTE的合并HR为1.26(95%CI 1.08-1.48),新发PVD的合并HR为1.27(95%CI 1.16-1.40)。作者认为不应忽视银屑病患者VTE或PVD的典型表现,应识别并治疗肥胖、缺乏运动、吸烟和静脉曲张等危险因素,慎用激素相关治疗等药物。
要点
- 银屑病患者新发VTE风险升高:合并HR 1.26(95%CI 1.08-1.48)。
- 银屑病患者新发PVD风险升高:合并HR 1.27(95%CI 1.16-1.40)。
- 亚组分析示银屑病关节炎、女性及亚洲和欧洲人群新发VTE风险升高。
核心结论
- 银屑病患者新发VTE和PVD的风险升高。
- 不应忽视银屑病患者VTE或PVD的典型表现。
- 应识别并治疗银屑病患者的肥胖、缺乏运动、吸烟和静脉曲张等危险因素,慎用激素相关治疗等药物。
研究设计与样本
- 系统评价与Meta分析,遵循MOOSE报告规范,检索MEDLINE、Embase、Cochrane Library、Web of Science和Cumulative Index to Nursing and Allied Health Literature从各库建库至2021年5月21日的文献,不限语言和地理区域。
- 由两名作者独立筛选队列研究,最终纳入13项队列研究共12 435 982名参与者进行定性分析,其中9项进行定量分析。
- 采用随机效应模型计算合并风险比(HR)及相应置信区间,并按关节炎状态、银屑病严重程度、性别和地理区域进行亚组分析。
主要发现
- 银屑病患者新发VTE的合并HR为1.26(95%CI 1.08-1.48)。
- 银屑病患者新发PVD的合并HR为1.27(95%CI 1.16-1.40)。
- 银屑病关节炎患者新发VTE的合并HR为1.24(95%CI 1.01-1.53)。
- 女性银屑病患者新发VTE的合并HR为1.89(95%CI 1.36-2.61)。
- 亚洲银屑病患者新发VTE的合并HR为2.02(95%CI 1.42-2.88),欧洲银屑病患者新发VTE的合并HR为1.28(95%CI 1.06-1.53)。
临床怎么用
- 作者认为,不应忽视银屑病患者VTE或PVD的典型表现。
- 作者建议,应识别并治疗银屑病患者的肥胖、缺乏运动、吸烟和静脉曲张等危险因素。
- 作者建议,银屑病患者使用激素相关治疗等药物时应谨慎。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Psoriasis, venous thromboembolism (VTE), and peripheral vascular disease (PVD) share similar mechanisms involving chronic inflammation. However, the associations between psoriasis and VTE or PVD are unclear. OBJECTIVE: To determine the association of psoriasis with incident VTE and PVD. DATA SOURCES: MEDLINE, Embase, Cochrane Library, Web of Science, and Cumulative Index to Nursing and Allied Health Literature were systematically searched for relevant publications from their respective inception through May 21, 2021. No restrictions on language or geographic locations were imposed. STUDY SELECTION: Two authors independently selected cohort studies that investigated the risk for incident VTE or PVD in patients with psoriasis. Any discrepancy was resolved through discussion with 2 senior authors until reaching consensus. Only 13 initially identified studies met the selection criteria for qualitative review, and only 9 of these for quantitative analysis. DATA EXTRACTION AND SYNTHESIS: The Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guideline was followed. Two authors independently extracted data and assessed the risk of bias of included studies by using the Newcastle-Ottawa Scale. Disagreements were resolved by discussion with 2 other authors. A random-effects model meta-analysis was conducted to calculate the pooled hazard ratios (HRs) with the corresponding confidence intervals for incident VTE and PVD. Subgroup analyses based on arthritis status, psoriasis severity, sex, and geographic location were also performed. MAIN OUTCOMES AND MEASURES: Hazard ratios for incident VTE and PVD associated with psoriasis. RESULTS: A total of 13 cohort studies with 12 435 982 participants were included. The meta-analysis demonstrated a significantly increased risk for incident VTE (pooled HR, 1.26; 95% CI, 1.08-1.48) and PVD (pooled HR, 1.27; 95% CI, 1.16-1.40) among patients with psoriasis. Subgroup analyses illustrated increased risk for incident VTE among participants with psoriatic arthritis (pooled HR, 1.24; 95% CI, 1.01-1.53), women (pooled HR, 1.89; 95% CI, 1.36-2.61), and those in Asia (pooled HR, 2.02; 95% CI, 1.42-2.88) and Europe (pooled HR, 1.28; 95% CI, 1.06-1.53). CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found an increased risk for incident VTE and PVD among patients with psoriatic disease. Typical presentations of VTE or PVD should not be overlooked in patients with psoriasis. Risk factors, such as obesity, physical inactivity, smoking, and varicose veins, should be identified and treated in patients with psoriasis, and medications like hormone-related therapies should be prescribed with caution.
引用
- Chen TL, Lee LL, Huang HK, et al. Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease: A Systematic Review and Meta-analysis. JAMA Dermatol. 2022. PMID: 34851364. doi:10.1001/jamadermatol.2021.4918
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。